Supernus Pharmaceuticals Aktie
31,60
EUR
-0,60
EUR
-1,86
%
33,06
USD
-1,53
USD
-4,42
%
Werbung
Supernus Pharmaceuticals Aktie Analyse
12.11.18 | Supernus Pharmaceuticals Buy | B. Riley FBR | |
18.01.18 | Supernus Pharmaceuticals Buy | B. Riley FBR, Inc. | |
28.12.17 | Supernus Pharmaceuticals Buy | B. Riley FBR, Inc. | |
08.11.17 | Supernus Pharmaceuticals Buy | Stifel, Nicolaus & Co., Inc. | |
19.10.17 | Supernus Pharmaceuticals Buy | FBR & Co. | |
19.09.17 | Supernus Pharmaceuticals Hold | Stifel, Nicolaus & Co., Inc. | |
05.11.15 | Supernus Pharmaceuticals Outperform | Northland Capital | |
28.10.15 | Supernus Pharmaceuticals Outperform | Northland Capital | |
Werbung
|
|||
18.06.15 | Supernus Pharmaceuticals Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung